BRIEF-Advisors Asset Management reports 5.126 percent passive stake in GDL Fund as of Dec 31, 2016
BRIEF-Insys says Cannabidiol Oral Solution for compassionate use studies being provided at no cost
* Insys therapeutics - providing for use of cannabidiol oral solution for compassionate use studies in patients completing long-term safety study